Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling

被引:87
作者
Ho, JMY
Beattie, BK
Squire, JA
Frank, DA
Barber, DL
机构
[1] Ontario Canc Inst, Div Cellular & Mol Biol, Toronto, ON M5G 2M9, Canada
[2] Toronto Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[4] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V93.12.4354.412k30_4354_4364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To study constitutive Janus kinase signaling, chimeric proteins were generated between the pointed domain of the ets transcription factor TEL and the cytosolic tyrosine kinase Jak2. The effects of these proteins on interleukin-3 (IL-3)-dependent proliferation of the hematopoietic cell line, Ba/F3, were studied, Fusion of TEL to the functional kinase (JH1) domain of Jak2 resulted in conversion of Ba/F3 cells to factor-independence. Importantly, fusion of TEL to the Jak2 pseudokinase (JH2) domain or a kinase-inactive Jak2 JH1 domain had no effect on IL-3-dependent proliferation of Ba/F3 cells. Active TEL-Jak2 constructs (consisting of either Jak2 JH1 or Jak2 JH2+JH1 domain fusions) were constitutively tyrosine-phosphorylated but did not affect phosphorylation of endogeneous Jak1, Jak2, or Jak3. TEL-Jak2 activation resulted in the constitutive tyrosine phosphorylation of Stat1, Stat3, and Stat5 as determined by detection of phosphorylation using activation-specific antibodies and by binding of each protein to a preferential GAS sequence in electrophoretic mobility shift assays. Elucidation of signaling events downstream of TEL Jak2 activation may provide insight into the mechanism of leukemogenesis mediated by this oncogenic fusion protein. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:4354 / 4364
页数:11
相关论文
共 64 条
[11]  
Frank DA, 1996, LEUKEMIA, V10, P1724
[12]   INTERLEUKIN-2 SIGNALING INVOLVES THE PHOSPHORYLATION OF STAT PROTEINS [J].
FRANK, DA ;
ROBERTSON, MJ ;
BONNI, A ;
RITZ, J ;
GREENBERG, ME .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7779-7783
[13]   Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130 .1. Definition of a novel phosphotyrosine motif mediating STAT1 activation [J].
Gerhartz, C ;
Heesel, B ;
Sasse, J ;
Hemmann, U ;
Landgraf, C ;
SchneiderMergener, J ;
Horn, F ;
Heinrich, PC ;
Graeve, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12991-12998
[14]   Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1 [J].
Gollob, JA ;
Murphy, EA ;
Mahajan, S ;
Schnipper, CP ;
Ritz, J ;
Frank, DA .
BLOOD, 1998, 91 (04) :1341-1354
[15]   The TEL gene and human leukemia [J].
Golub, TR ;
McLean, T ;
Stegmaier, K ;
Carroll, M ;
Tomasson, M ;
Gilliland, DG .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1288 (01) :M7-M10
[16]   FUSION OF PDGF RECEPTOR-BETA TO A NOVEL ETS-LIKE GENE, TEL, IN CHRONIC MYELOMONOCYTIC LEUKEMIA WITH T(512) CHROMOSOMAL TRANSLOCATION [J].
GOLUB, TR ;
BARKER, GF ;
LOVETT, M ;
GILLILAND, DG .
CELL, 1994, 77 (02) :307-316
[17]  
Golub TR, 1996, MOL CELL BIOL, V16, P4107
[18]   FUSION OF THE TEL GENE ON 12P13 TO THE AML1 GENE ON 21Q22 IN ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
GOLUB, TR ;
BARKER, GF ;
BOHLANDER, SK ;
HIEBERT, SW ;
WARD, DC ;
BRAYWARD, P ;
MORGAN, E ;
RAIMONDI, SC ;
ROWLEY, JD ;
GILLILAND, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4917-4921
[19]  
Gotoh A, 1997, Curr Opin Hematol, V4, P3
[20]   PROLACTIN, GROWTH-HORMONE, ERYTHROPOIETIN AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INDUCE MGF-STAT5 DNA-BINDING ACTIVITY [J].
GOUILLEUX, F ;
PALLARD, C ;
DUSANTERFOURT, I ;
WAKAO, H ;
HALDOSEN, LA ;
NORSTEDT, G ;
LEVY, D ;
GRONER, B .
EMBO JOURNAL, 1995, 14 (09) :2005-2013